The key initial Quality Performance Indicators for Melanoma Cancer, have been met in 2020/2022, for more than 96% of those referred. This is up from 91.5% in 2018/2019 and beats the 90% target by some way.
QP1 definition:
Proportion of patients with cutaneous melanoma who have their initial diagnostic biopsy carried out by a skin cancer clinician*.
https://acrobat.adobe.com/link/track?uri=urn:aaid:scds:US:32e1f3e7-9e87-4356-9d46-014c605df879#pageNum=7
Talking-up Scotland 